LBPH
Longboard Pharmaceuticals, Inc. (LBPH)
Last Price$60.00.0%
Market Cap$2,336.7M
LTM Dividend per Share (DPS)
$0.0
5Y avg
$0.0
Biotechnology industry median
$0.0
Stock quality & Intrinsic value
6/10
(0.8%) overvalued

Longboard Pharmaceuticals, Inc. Dividend per Share (DPS)

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'21Dec'22Dec'23
Dividend per Share (DPS)
$0.0
$0.0
$0.0
LBPH
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for LBPH and see if it's the right time to invest.
Dive in

Longboard Pharmaceuticals, Inc. (LBPH) Dividend per Share (DPS) comparison analysis

LBPH key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'20Dec'21Dec'22Dec'23
% growth
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
Cost of Goods Sold (COGS)0.00.00.00.0
% margin
0.0
0.0%
(0.0)
0.0%
(0.0)
0.0%
(0.0)
0.0%
Operating Expenses14.427.844.856.8
Research & Development Expenses (R&D)4.619.834.643.8
Selling, General & Administrative Expenses (SG&A)9.88.110.213.0
(14.4)
0.0%
(27.8)
0.0%
(44.8)
0.0%
(56.8)
0.0%
Interest Income0.00.10.82.4
Interest Expense0.00.00.80.0
Pre-tax Income(14.4)(27.8)(43.9)(54.4)
% effective tax rate
(0.0)
0.1%
(0.1)
0.2%
(0.9)
1.9%
0.0
0.0%
% margin
(14.4)
0.0%
(27.7)
0.0%
(43.1)
0.0%
(54.4)
0.0%
EPS(0.82)(1.62)(2.51)(2.39)
Diluted EPS(0.82)(1.62)(2.51)(2.39)
% margin
(14.4)
0.0%
(27.8)
0.0%
(44.8)
0.0%
(56.8)
0.0%

Discover more Stock Ideas

FAQ

1) What is Longboard Pharmaceuticals, Inc.'s Dividend per Share (DPS)?

As of today, Longboard Pharmaceuticals, Inc.'s last 12-month Dividend per Share (DPS) is $0.0, based on the financial report for Sep 30, 2024 (Q3’2024).

2) What is Longboard Pharmaceuticals, Inc.'s Dividend per Share (DPS) growth rate?

Over the last year, Longboard Pharmaceuticals, Inc.'s Dividend per Share (DPS) growth was N/A. The average annual Dividend per Share (DPS) growth rates for Longboard Pharmaceuticals, Inc. have been N/A over the past three years, N/A over the past five years.